10.1523/JNEUROSCI.4703-13.2014
Separately, Pfizer entered a $2.085B deal with YaoPharma (Dec 2025) for a GLP-1 asset, and a $495M deal with Sciwind Biosciences (Feb 2026) to commercialize ecnoglutide in China
Conclusion GLP1 receptor agonists continue to play a major role in diabetes and obesity management
Soboba serves patients through locations in Newport Beach , Laguna Hills , and Rancho Santa Margarita , making it easier for people throughout Orange County to find a location that works for them
One consequence of this popularity is that despite their high cost, the GLP-1 agonist medications have seen demand outstrip their supply resulting in shortages making their availability to treat diabetes more limited
Glickman says that while you should expect to pay up to $1,400 monthly without insurance, there are cheaper options if youre on a budget: Assistance programs or manufacturer discounts may help reduce costs, and there are compounded options available at lower costs, he notes